Teligent Free Cash Flow 2010-2021 | TLGT
Teligent free cash flow from 2010 to 2021. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| Teligent Annual Free Cash Flow |
| 2020 |
-20.66 |
| 2019 |
-26.62 |
| 2018 |
-38.57 |
| 2017 |
-40.03 |
| 2016 |
-17.10 |
| 2015 |
-21.51 |
| 2014 |
-4.73 |
| 2013 |
-0.91 |
| 2012 |
-2.72 |
| 2011 |
-2.74 |
| 2010 |
-3.21 |
| 2009 |
-4.35 |
| Teligent Quarterly Free Cash Flow |
| 2021-06-30 |
-17.64 |
| 2021-03-31 |
-10.92 |
| 2020-12-31 |
-20.66 |
| 2020-09-30 |
-18.77 |
| 2020-06-30 |
-13.51 |
| 2020-03-31 |
-3.83 |
| 2019-12-31 |
-26.62 |
| 2019-09-30 |
-14.74 |
| 2019-06-30 |
-15.39 |
| 2019-03-31 |
-8.18 |
| 2018-12-31 |
-38.57 |
| 2018-09-30 |
-33.59 |
| 2018-06-30 |
-25.03 |
| 2018-03-31 |
-13.64 |
| 2017-12-31 |
-40.03 |
| 2017-09-30 |
-28.66 |
| 2017-06-30 |
-16.59 |
| 2017-03-31 |
-6.67 |
| 2016-12-31 |
-17.10 |
| 2016-09-30 |
-9.14 |
| 2016-06-30 |
-2.51 |
| 2016-03-31 |
0.20 |
| 2015-12-31 |
-21.51 |
| 2015-09-30 |
-2.41 |
| 2015-06-30 |
-7.07 |
| 2015-03-31 |
-0.33 |
| 2014-12-31 |
-4.73 |
| 2014-09-30 |
-1.65 |
| 2014-06-30 |
-0.78 |
| 2014-03-31 |
-0.01 |
| 2013-12-31 |
-0.91 |
| 2013-09-30 |
-1.61 |
| 2013-06-30 |
-1.10 |
| 2013-03-31 |
-1.65 |
| 2012-12-31 |
-2.72 |
| 2012-09-30 |
-1.52 |
| 2012-06-30 |
-1.27 |
| 2012-03-31 |
-0.73 |
| 2011-12-31 |
-2.74 |
| 2011-09-30 |
-2.69 |
| 2011-06-30 |
-2.29 |
| 2011-03-31 |
-0.98 |
| 2010-12-31 |
-3.21 |
| 2010-09-30 |
-2.44 |
| 2010-06-30 |
-2.38 |
| 2010-03-31 |
-1.18 |
| 2009-12-31 |
-4.35 |
| 2009-09-30 |
-2.99 |
| 2009-06-30 |
-1.80 |
| 2009-03-31 |
-0.97 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.000B |
$0.000B |
|
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
|
